On the public citation graph
Simultaneous Integrated Boost and Protection Proton Beam Therapy Approach for Hepatocellular Carcinoma
0 signed · 26 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.25809openalex-extracted
The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial
inferredcites →https://doi.org/10.1002/cncr.26134openalex-extracted
Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.29878openalex-extracted
Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
inferredcites →https://doi.org/10.1007/s00066-019-01488-9openalex-extracted
Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/0360-3016(94)00418-kopenalex-extracted
Hepatic toxicity resulting from cancer treatment
inferredcites →https://doi.org/10.1016/j.adro.2021.100675openalex-extracted
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.02.030openalex-extracted
Proton Beam Therapy for Large Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.06.092openalex-extracted
Radiation-Associated Liver Injury
inferredcites →https://doi.org/10.1016/j.ijrobp.2010.03.015openalex-extracted
Proton Beam Therapy for Hepatocellular Carcinoma Located Adjacent to the Alimentary Tract
inferredcites →https://doi.org/10.1016/j.ijrobp.2010.07.015openalex-extracted
Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols
inferredcites →https://doi.org/10.1016/j.ijrobp.2011.11.058openalex-extracted
Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.ijrobp.2019.01.076openalex-extracted
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival
inferredcites →https://doi.org/10.1016/j.ijrobp.2021.10.006openalex-extracted
LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.prro.2021.09.004openalex-extracted
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
inferredcites →https://doi.org/10.1016/j.radonc.2016.12.014openalex-extracted
Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis
inferredcites →https://doi.org/10.1016/j.radonc.2018.10.041openalex-extracted
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1118/1.4916662openalex-extracted
Motion mitigation for lung cancer patients treated with active scanning proton therapy
inferredcites →https://doi.org/10.1186/s13014-020-01605-4openalex-extracted
Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
inferredcites →https://doi.org/10.1186/s13014-020-01703-3openalex-extracted
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
inferredcites →https://doi.org/10.1200/jco.2015.64.2710openalex-extracted
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
inferredcites →https://doi.org/10.1200/jop.2017.022996openalex-extracted
Medical Management of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3389/fonc.2020.00542openalex-extracted
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3390/cancers14235842openalex-extracted
Long-Term Results of Proton Therapy for Hepatocellular Carcinoma Using Four-Dimensional Computed Tomography Planning without Fiducial Markers
inferredcites →https://doi.org/10.3748/wjg.v16.i14.1800openalex-extracted
Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.3322/caac.21660openalex-snapshot
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.